Candidiasis of vulva and vagina
ICD-10 B37.1 is a billable code used to indicate a diagnosis of candidiasis of vulva and vagina.
Candidiasis of the vulva and vagina, commonly known as a yeast infection, is a fungal infection caused primarily by the organism Candida albicans. This condition is characterized by symptoms such as itching, burning, and abnormal vaginal discharge, which may appear thick and white, resembling cottage cheese. The infection can occur in women of all ages and is often associated with factors such as antibiotic use, hormonal changes, diabetes, and immunocompromised states. In immunocompromised patients, such as those with HIV/AIDS or undergoing chemotherapy, the risk of developing candidiasis increases significantly due to a weakened immune response. Diagnosis is typically made through clinical evaluation and may be confirmed by laboratory tests, including culture or microscopic examination of vaginal secretions. Treatment usually involves antifungal medications, which can be administered topically or orally, depending on the severity of the infection. It is crucial for healthcare providers to consider underlying conditions that may predispose patients to recurrent infections and to provide appropriate education on preventive measures.
Detailed patient history, including symptoms, previous infections, and treatment responses.
Patients presenting with recurrent yeast infections or those with risk factors such as diabetes or antibiotic use.
Consideration of differential diagnoses and the impact of hormonal changes on candidiasis.
Comprehensive assessment of the patient's immune status and any underlying conditions.
Immunocompromised patients presenting with atypical or severe candidiasis.
Need for thorough documentation of treatment regimens and follow-up care.
Used when laboratory confirmation of candidiasis is required.
Document the reason for the culture and any previous treatments.
Obstetrics and Gynecology may require additional documentation for pregnancy-related cases.
Common treatments include topical antifungals such as clotrimazole or miconazole, and oral antifungals like fluconazole. The choice of treatment depends on the severity and frequency of infections.
